Financials

Discussions Seasonals

APUS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Apimeds Pharmaceuticals US, Inc. operating, investing, and financing activities

APUS free cash flow for Q4 24 is -99.62 k USD. For 2024, APUS free cash flow was -733.53 k USD and operating cash flow was -733.53 k USD.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—